Tara Health and a collaborative of leading reproductive health foundations and investors engaged the Camber Collective to map the landscape of the U.S. reproductive health market. We commissioned a report to better understand the sector’s most pressing needs and to identify areas for investment across asset classes that have a high potential to improve access to and quality of reproductive health products and services. See the link to the report below.
Ideas & Resources
Tara Health is proud to support research and evidence-based best practices. In the past year, we supported the publication of these four reports.
Abortion is a safe and effective form of healthcare, concludes a report released from the National Academies of Sciences, Engineering, and Medicine. The report, The Safety and Quality of Abortion Care in the Unites States, was released in March of 2018 and co-sponsored by Tara Health. This evidence-based, non-partisan, scientific research - developed by an independent panel of 16 field experts - is the first comprehensive look at abortion safety, access and care conducted in the last 40 years. The biggest threat to quality abortion care, the research found, is the litany of medically unnecessary regulations that raise costs and delay procedures.
The U.S. Reproductive Health Investment Case was commissioned by the Reproductive Health Investors Alliance Steering Committee. It is dedicated to increasing the total amount of philanthropy and impact investment directed toward high-impact opportunities that increase American women’s ability to manage their fertility in a safe and dignified manner. The report includes a detailed landscape analysis of reproductive health needs in the U.S., a systems view of the actors and issues that affect access to high quality contraception & abortion services, and a set of strategic investment opportunities.
The Center for High Impact Philanthropy (CHIP), with the support of Tara Health, released The XX Factor in 2017. The report examines the inequalities and opportunities afforded to women and girls and provides the first comprehensive and evidence-based framework to help funders take action. The framework identifies the five dimensions of a woman’s life that are critical to her flourishing: Economic Empowerment, Education, Health, Legal Rights, and Personal Safety. The framework also identifies outcome measures that mark progress in women’s lives and the evidence-based strategies that work to improve those measures.
As recently as five years ago, there were few options for structured venture capital and debt vehicles moving capital with a gender lens. Interested investors had little access to or knowledge of the key players, vehicles and opportunities in this burgeoning field of finance. Tara Health was pleased to support Project Sage: Tracking Venture Capital with a Gender Lens, authored by Suzanne Biegel, Sandra M. Hunt, and Sherryl Kuhlman as part of the Wharton Social Impact Initiative at the University of Pennsylvania. The report maps funds and provides a point-in-time look at private equity and debt funds that publicly state the use of a gender lens.
Abortion is a safe and effective form of healthcare, concludes The Safety and Quality of Abortion Care in the Unites States, a report released in March of 2018 by the National Academies of Sciences, Engineering, and Medicine with support from Tara Health.
Download the report above and for more information and to #GetTheFacts, please visit http://abortionissafe.com/.
Tara Health was honored that Bank of America, in their 2017 Annual Report, highlighted the work of our Founder and Executive Director, Ruth Shaber, in impact investing. Tara Health has a strong partnership with Merrill Lynch Wealth Management Advisors, Mary Foust and Alena Meeker, to support a diverse investment portfolio that is 100% aligned with values and mission.
"When Dr. Ruth Shaber started here career as an obstetrician and gynecologist in San Francisco, impact investing was virtually unknown. Today, it's hard to imagine an investment conversation that doesn't begin and end with how to use capital to drive both social and financial return...." Read more.
An early release of the U.S. Reproductive Health Investment Case was shared with 75+ national experts, in reproductive health and impact investing, at a day-long convening in October of 2017 in San Francisco. See above to download the report.
View a slideshow of photos (left) from the event.